首页> 外国专利> TREATMENT OR PROPHYLAXIS OF PROSTATIC CANCER AND BENIGN PROSTATIC HYPERPLASIA WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS

TREATMENT OR PROPHYLAXIS OF PROSTATIC CANCER AND BENIGN PROSTATIC HYPERPLASIA WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS

机译:选择性雌激素受体调节剂治疗或预防前列腺癌和良性前列腺增生症

摘要

The present invention provides a method for the treatment or prophylaxis of benign prostatic hyperplasia or prostatic cancer in a patient in need of such treatment comprising administering a selective estrogen receptor modulating compound of formula (I), in which R1 and R2 are independently hydroxy and alkoxy of one to four carbon atoms; and R3 and R4 are independently methyl or ethyl, or R3 and R4, taken together with the nitrogen atom to which they are attached, form a pyrrolidino, methyl-pyrrolidino, dimethylpyrrolidino, piperidino, morpholino, or hexamethyleneimino ring.
机译:本发明提供了用于在需要这种治疗的患者中治疗或预防良性前列腺增生或前列腺癌的方法,该方法包括施用式(I)的选择性雌激素受体调节化合物,其中R 1和R 2 >分别为1-4个碳原子的羟基和烷氧基; R 3和R 4独立地为甲基或乙基,或R 3和R 4与它们所连接的氮原子一起形成吡咯烷基,甲基吡咯烷基,二甲基吡咯烷基,哌啶子基,吗啉代或六亚甲基亚氨基环。

著录项

  • 公开/公告号EP0975629A4

    专利类型

  • 公开/公告日2001-03-21

    原文格式PDF

  • 申请/专利权人 ELI LILLY AND COMPANY;

    申请/专利号EP19980915488

  • 发明设计人 NEUBAUER BLAKE LEE;

    申请日1998-04-07

  • 分类号C07D409/12;A61K31/535;A61K31/38;

  • 国家 EP

  • 入库时间 2022-08-22 01:16:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号